Skip to main content
PMC home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2004;12(1):31–40. doi: 10.1080/1064744042000210384

Visceral leishmaniasis (kala-azar) and pregnancy.

Ernesto Antonio Figueiró-Filho 1, Geraldo Duarte 1, Patrícia El-Beitune 1, Silvana Maria Quintana 1, Tamara Lemos Maia 1
PMCID: PMC1784584  PMID: 15460194

Abstract

OBJECTIVE: The aim of the present review was to close the gap in the approach to pregnant women with visceral leishmaniasis (kala-azar) by providing up-to-date information to obstetricians about physiopathology, epidemiology, vertical transmission, drugs and treatment during pregnancy. BACKGROUND: Infection with Leishmania chagasi during pregnancy is rare and deserves special attention since little information is available regarding the occurrence of visceral leishmaniasis during gestational period and the real possibility of vertical transmission of this disease. Because specific areas in the world are endemic for the disease and considering the continuous growth of the population, cases of pregnant women with visceral leishmaniasis are becoming more frequent. Unfortunately, textbooks on infectious diseases do not include this specific group of patients, and studies in the literature on aspects related to pregnancy and visceral leishmaniasis are scarce. CONCLUSIONS: Vertical transmission of leishmaniasis is possible and the institution of treatment is imperative in cases of pregnant women with kala-azar. Amphotericin B is strongly recommended as the first choice drug due to its fewer maternal-fetal adverse effects.

Full Text

The Full Text of this article is available as a PDF (91.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrade Hélida M., de Toledo Vicente de P. C. P., Marques Marcos José, França Silva João C., Tafuri Wagner L., Mayrink Wilson, Genaro Odair. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Vet Parasitol. 2002 Jan 3;103(1-2):71–81. doi: 10.1016/s0304-4017(01)00552-0. [DOI] [PubMed] [Google Scholar]
  2. BANERJI D. Possible congenital infection of kala-azar. J Indian Med Assoc. 1955 Mar 1;24(11):433–435. [PubMed] [Google Scholar]
  3. Barber J. S., Trees A. J. Naturally occurring vertical transmission of Neospora caninum in dogs. Int J Parasitol. 1998 Jan;28(1):57–64. doi: 10.1016/s0020-7519(97)00171-9. [DOI] [PubMed] [Google Scholar]
  4. Blanc C., Robert A. Cinquième observation de kala-azar congénital. Presse Med. 1984 Jul 7;13(28):1751–1751. [PubMed] [Google Scholar]
  5. Caldas Arlene J. M., Costa Jackson M. L., Gama Mônica E. A., Ramos Eduardo A. G., Barral Aldina. Visceral leishmaniasis in pregnancy: a case report. Acta Trop. 2003 Sep;88(1):39–43. doi: 10.1016/s0001-706x(03)00160-8. [DOI] [PubMed] [Google Scholar]
  6. De Raadt P. Trypanosomoses et leishmanioses congénitales. Arch Fr Pediatr. 1985 Dec;42 (Suppl 2):925–927. [PubMed] [Google Scholar]
  7. Dubey J. P., Koestner A., Piper R. C. Repeated transplacental transmission of Neospora caninum in dogs. J Am Vet Med Assoc. 1990 Oct 1;197(7):857–860. [PubMed] [Google Scholar]
  8. Elamin A., Omer M. I. Visceral leishmaniasis in a 6-week-old infant: possible congenital transmission. Trop Doct. 1992 Jul;22(3):133–135. doi: 10.1177/004947559202200326. [DOI] [PubMed] [Google Scholar]
  9. Eltoum I. A., Zijlstra E. E., Ali M. S., Ghalib H. W., Satti M. M., Eltoum B., el-Hassan A. M. Congenital kala-azar and leishmaniasis in the placenta. Am J Trop Med Hyg. 1992 Jan;46(1):57–62. doi: 10.4269/ajtmh.1992.46.57. [DOI] [PubMed] [Google Scholar]
  10. Giri O. P. Amphotericin B therapy in kala-azar. J Indian Med Assoc. 1993 Apr;91(4):91–93. [PubMed] [Google Scholar]
  11. Gradoni L., Gaeta G. B., Pellizzer G., Maisto A., Scalone A. Mediterranean visceral leishmaniasis in pregnancy. Scand J Infect Dis. 1994;26(5):627–629. doi: 10.3109/00365549409011824. [DOI] [PubMed] [Google Scholar]
  12. Gürtler R. E., Lauricella M., Solarz N. D., Bujas M. A., Wisnivesky-Colli C. Dynamics of transmission of Trypanosoma cruzi in a rural area of Argentina. I--The dog reservoir: an epidemiological profile. Rev Inst Med Trop Sao Paulo. 1986 Jan-Feb;28(1):28–35. doi: 10.1590/s0036-46651986000100006. [DOI] [PubMed] [Google Scholar]
  13. Harvey J. W., Taboada J., Lewis J. C. Babesiosis in a litter of pups. J Am Vet Med Assoc. 1988 Jun 15;192(12):1751–1752. [PubMed] [Google Scholar]
  14. Krakowka S. Transplacentally acquired microbial and parasitic diseases of dogs. J Am Vet Med Assoc. 1977 Oct 15;171(8):750–753. [PubMed] [Google Scholar]
  15. Krishnan L., Guilbert L. J., Russell A. S., Wegmann T. G., Mosmann T. R., Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines. J Immunol. 1996 Jan 15;156(2):644–652. [PubMed] [Google Scholar]
  16. Kumar A., Mittal M., Prasad S. Treatment of leishmaniasis in pregnancy. Int J Gynaecol Obstet. 2001 Feb;72(2):189–190. doi: 10.1016/s0020-7292(00)00362-3. [DOI] [PubMed] [Google Scholar]
  17. Léonard A., Gerber G. B. Mutagenicity, carcinogenicity and teratogenicity of antimony compounds. Mutat Res. 1996 Oct;366(1):1–8. doi: 10.1016/s0165-1110(96)90003-2. [DOI] [PubMed] [Google Scholar]
  18. Mittal V., Sehgal S., Yadav T. P., Singh V. K. Congenital transmission of kala-azar. J Commun Dis. 1987 Jun;19(2):184–185. [PubMed] [Google Scholar]
  19. Nuwayri-Salti N., Fallah Khansa H. Direct non-insect-vector transmission of Leishmania parasites in mice. Int J Parasitol. 1985 Oct;15(5):497–500. doi: 10.1016/0020-7519(85)90043-8. [DOI] [PubMed] [Google Scholar]
  20. Nyakundi P. M., Muigai R., Were J. B., Oster C. N., Gachihi G. S., Kirigi G. Congenital visceral leishmaniasis: case report. Trans R Soc Trop Med Hyg. 1988;82(4):564–564. doi: 10.1016/0035-9203(88)90508-1. [DOI] [PubMed] [Google Scholar]
  21. Paumgartten F. J., Chahoud I. Embryotoxicity of meglumine antimoniate in the rat. Reprod Toxicol. 2001 May-Jun;15(3):327–331. doi: 10.1016/s0890-6238(01)00127-7. [DOI] [PubMed] [Google Scholar]
  22. Sharma R., Bahl L., Goel A., Upadhaya A., Kaushik S. L., Sharma R. L., Gupta A. Congenital kala-azar: a case report. J Commun Dis. 1996 Mar;28(1):59–61. [PubMed] [Google Scholar]
  23. Thakur C. P., Singh R. K., Hassan S. M., Kumar R., Narain S., Kumar A. Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases. Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):319–323. doi: 10.1016/s0035-9203(99)90037-8. [DOI] [PubMed] [Google Scholar]
  24. Thakur C. P., Sinha G. P., Sharma V., Barat D. The treatment of kala-azar during pregnancy. Natl Med J India. 1993 Nov-Dec;6(6):263–265. [PubMed] [Google Scholar]
  25. Utili R., Rambaldi A., Tripodi M. F., Andreana A. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate. Infection. 1995 May-Jun;23(3):182–183. doi: 10.1007/BF01793862. [DOI] [PubMed] [Google Scholar]
  26. Vieira J. B., Coelho G. E. Leishmaniose visceral ou calazar: aspectos epidemiológicos e de controle. Rev Soc Bras Med Trop. 1998;31 (Suppl 2):85–92. [PubMed] [Google Scholar]
  27. Wegmann T. G., Lin H., Guilbert L., Mosmann T. R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today. 1993 Jul;14(7):353–356. doi: 10.1016/0167-5699(93)90235-D. [DOI] [PubMed] [Google Scholar]
  28. Winship K. A. Toxicity of antimony and its compounds. Adverse Drug React Acute Poisoning Rev. 1987 Summer;6(2):67–90. [PubMed] [Google Scholar]
  29. Yadav T. P., Gupta H., Satteya U., Kumar R., Mittal V. Congenital kala-azar. Ann Trop Med Parasitol. 1989 Oct;83(5):535–537. doi: 10.1080/00034983.1989.11812383. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES